| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |